EpCAM-Targeted Surface-Enhanced Raman Spectroscopy Nanotags for Rapid Evaluation of Surgical Margins and Sentinel Lymph Node Metastasis Status in Breast Cancers

Launched by YUNNAN CANCER HOSPITAL · Jun 4, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring a new method to help doctors assess whether breast cancer has been completely removed during surgery and to check if cancer has spread to nearby lymph nodes. The trial is testing a special technology that quickly analyzes tissue samples taken during surgery. This method aims to provide faster and more accurate results, which could lead to better outcomes for patients by reducing the chance of cancer returning and minimizing complications.

To participate in this trial, women aged 18 to 75 who have been diagnosed with breast cancer and are eligible for surgery may be considered. Participants will need to be able to understand and agree to take part in the study. However, those with serious health issues that could affect surgery or who cannot give consent will not be included. If you join the trial, you can expect to have your tissue samples analyzed right away during your surgery, which could help your doctors make quicker decisions about your treatment.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Adult patients between 18-75 years of age
• • Female
• • Patients presenting with a breast cancer to be resectable on pre-operative assessment
• • Good operative candidate
• • Subject capable of giving informed consent and participating in the process of consent
• Exclusion Criteria:
• • Patients unable to participate in the consent process
• • Patients had contraindications to surgery, such as serious cardiopulmonary disease, coagulation dysfunction, etc
• • Other conditions that the researcher considers inappropriate to participate in the study